Jun. 22 at 3:37 PM
$AMTM from SA today Summary
Amentum is deeply undervalued, trading at less than 9x forward earnings and 8x EV/EBITDA, with strong government-aligned tailwinds.
AMTM’s
$47.8B backlog and shift toward higher-margin, fixed-price contracts position it for margin expansion and potential multiple re-rating.
Deleveraging from 4.1x to a 3.0x net debt/EBITDA target, with recent refinancing saving ~
$19.6M in annual interest, will unlock shareholder value.
Peer multiples and EBITDA sensitivity suggest 31–60% upside, with catalysts including nuclear contract wins, margin improvement, and possible share repurchases.
